萬順新材(300057.SZ):不提前贖回“萬順轉2”
格隆匯9月30日丨萬順新材(300057.SZ)公佈,2021年9月29日,公司第五屆董事會第二十五次會議審議通過了《關於不提前贖回萬順轉2的議案》,結合當前市場情況及公司自身實際情況,出於保護投資者利益的考慮,同意自本議案審議通過之日至2021年12月31日不行使萬順轉2的提前贖回權利,不提前贖回萬順轉2。以 2022 年1月1 日後首個交易日重新計算萬順轉2 有條件贖回條款,屆時將另行決定是否行使萬順轉2 的提前贖回權利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.